IEV2MOL is an AI model developed by Tokyo Institute of Technology (Japan), first published in October 2024. It works in the biology domain, on tasks such as drug discovery.
Epoch AI has no training-compute estimate for this model. It was trained on roughly 73.6M datapoints.
Epoch AI rates the confidence of this record as likely.